Vident Investment Advisory, LLC Replimune Group, Inc. Transaction History

Vident Investment Advisory, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$17.48 - $29.09 $15,766 - $26,239	-902 Reduced 3.33%	26,161 $462,000
Q4 2022 Feb 14, 2023	SELL	$17.09 - $27.91 $258,845 - $422,724	-15,146 Reduced 35.88%	27,063 $736,000
Q3 2022 Nov 14, 2022	SELL	$15.6 - $21.15 $70,574 - $95,682	-4,524 Reduced 9.68%	42,209 $729,000
Q2 2022 Aug 15, 2022	BUY	$13.32 - $19.98 $22,031 - $33,046	1,654 Added 3.67%	46,733 $817,000
Q1 2022 May 16, 2022	BUY	$15.24 - $29.75 $114,528 - $223,571	7,515 Added 20.01%	45,079 $765,000
Q4 2021 Feb 14, 2022	SELL	$25.43 - $34.25 $164,862 - $222,042	-6,483 Reduced 14.72%	37,564 $1.02 Million
Q3 2021 Nov 12, 2021	SELL	$28.98 - $39.54 $91,171 - $124,392	-3,146 Reduced 6.67%	44,047 $1.31 Million
Q2 2021 Aug 13, 2021	BUY	$28.5 - $39.37 $268,783 - $371,298	9,431 Added 24.97%	47,193 $1.81 Million
Q1 2021 May 14, 2021	SELL	$30.22 - $45.57 $5,167 - $7,792	-171 Reduced 0.45%	37,762 $1.15 Million
Q4 2020 Feb 08, 2021	SELL	$23.5 - $52.65 $526,846 - $1.18 Million	-22,419 Reduced 37.15%	37,933 $1.45 Million
Q3 2020 Nov 12, 2020	SELL	$18.85 - $27.0 $78,189 - $111,996	-4,148 Reduced 6.43%	60,352 $1.39 Million
Q2 2020 Jul 17, 2020	BUY	$9.76 - $25.95 $629,520 - $1.67 Million	64,500 New	64,500 $1.6 Million

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $694M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.